M&A / Deals Beeline raises $300m for BMS drugs, and other biofinancings PharmaphorumBeeline Medicines, Oricell, Terremoto, Harbinger, Neomorph, Adcendo, and STORM all closed impressive financing rounds in the last week.M&A / DealsRead full story pharminent April 16, 2026 (Last updated: April 16, 2026) Pharmaphorum Beeline Medicines, Oricell, Terremoto, Harbinger, Neomorph, Adcendo, and STORM all closed impressive financing rounds in the last week. M&A / DealsRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Most patients “won’t see benefit” with Alzheimer’s drugsNext: Revolution doubles stock offering target to $2B following pancreatic cancer win Related Stories M&A / Deals Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar pharminent July 10, 2026 M&A / Deals GSK ends dementia alliance with Alector after setbacks pharminent July 9, 2026 M&A / Deals AstraZeneca, GSK intensify China ties with Sino Biopharm deals pharminent July 8, 2026
